Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer
Authors
Keywords
-
Journal
Biomedicines
Volume 11, Issue 6, Pages 1610
Publisher
MDPI AG
Online
2023-06-02
DOI
10.3390/biomedicines11061610
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A recombinant scFv antibody-based fusion protein that targets EGFR associated with IMPDH2 downregulation and its drug conjugate show therapeutic efficacy against esophageal cancer
- (2022) Shiming He et al. DRUG DELIVERY
- CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer
- (2022) Hongjia Zhu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- PD-1 N58-Glycosylation-Dependent Binding of Monoclonal Antibody Cemiplimab for Immune Checkpoint Therapy
- (2022) Dan Lu et al. Frontiers in Immunology
- Strategies and Considerations for Improving Recombinant Antibody Production and Quality in Chinese Hamster Ovary Cells
- (2022) Jun-He Zhang et al. Frontiers in Bioengineering and Biotechnology
- Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma
- (2022) Godfrey Chi-Fung Chan et al. Biomolecules
- Epitope Mapping of Rituximab Using HisMAP Method
- (2022) Teizo Asano et al. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
- Mosunetuzumab: First Approval
- (2022) Connie Kang DRUGS
- Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance
- (2022) Xinlei Zhuang et al. Nature Communications
- The High-Resolution Structure Reveals Remarkable Similarity in PD-1 Binding of Cemiplimab and Dostarlimab, the FDA-Approved Antibodies for Cancer Immunotherapy
- (2022) Tae-Jun Jeong et al. Biomedicines
- Immune Functions of Signaling Lymphocytic Activation Molecule Family Molecules in Multiple Myeloma
- (2021) Mariko Ishibashi et al. Cancers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
- (2021) Gilles Salles et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Anti-EGFR antibody 528 binds to domain III of EGFR at a site shifted from the cetuximab epitope
- (2021) Koki Makabe et al. Scientific Reports
- A single-chain antibody generation system yielding CAR-T cells with superior antitumor function
- (2021) Toshiki Ochi et al. Communications Biology
- Determination of the Rituximab Binding Site to the CD20 Epitope Using SPOT Synthesis and Surface Plasmon Resonance Analyses
- (2021) Laure Bar et al. ANALYTICAL CHEMISTRY
- CD70-specific CAR T-cells have potent activity against Acute Myeloid Leukemia (AML) without HSC toxicity
- (2021) Tim Sauer et al. BLOOD
- RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480
- (2021) Chen-Chen Huang et al. BMC CANCER
- Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET
- (2021) Joost Neijssen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
- (2021) Robert L Coleman et al. LANCET ONCOLOGY
- Comparison of the Efficacy and Safety of Anti-CD20 B Cells Depleting Drugs in Multiple Sclerosis
- (2021) Kelly R. Cotchett et al. Multiple Sclerosis and Related Disorders
- Recombinant antibodies and their use for food immunoanalysis
- (2021) Riikka Peltomaa et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Inhibition of human lung cancer cells by anti-p21Ras scFv mediated by the activatable cell-penetrating peptide
- (2021) Yu Du et al. ANTI-CANCER DRUGS
- Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety
- (2021) Massimo Offidani et al. Drug Design Development and Therapy
- A Cluster Analysis of Risk Factors for Cancer across EU Countries: Health Policy Recommendations for Prevention
- (2021) Dawid Majcherek et al. International Journal of Environmental Research and Public Health
- GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma
- (2021) Felix Zirngibl et al. Journal for ImmunoTherapy of Cancer
- Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma
- (2021) Pier Luigi Zinzani et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A method of delivering an anti-p21Ras single-chain antibody fragment to tumor sites in vivo
- (2021) Peng Wang et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy
- (2021) Zhaohuan Li et al. JOURNAL OF NANOBIOTECHNOLOGY
- Therapeutic effiacy of T cells expressing chimeric antigen receptor derived from a mesothelin-specific scFv in orthotopic human pancreatic cancer animal models
- (2021) Hyeon Ho Lee et al. NEOPLASIA
- Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy
- (2021) Kajal H. Gupta et al. Vaccines
- Structural insights into the cis and trans assembly of human trophoblast cell surface antigen 2
- (2021) Meng Sun et al. iScience
- Molecular profiling for precision cancer therapies
- (2020) Eoghan R. Malone et al. Genome Medicine
- Epitope and Paratope Mapping of PD-1/Nivolumab by Mass Spectrometry-based Hydrogen/Deuterium Exchange, Cross-linking, and Molecular Docking
- (2020) Mengru Mira Zhang et al. ANALYTICAL CHEMISTRY
- Dual in vitro invasion/migration suppressing and tamoxifen response modulating effects of a recombinant anti-ALCAM scFv on breast cancer cells
- (2020) Behrad Darvishi et al. CELL BIOCHEMISTRY AND FUNCTION
- How to select IgG subclasses in developing anti-tumor therapeutic antibodies
- (2020) Jifeng Yu et al. Journal of Hematology & Oncology
- The world of cell penetrating: the future of medical applications
- (2020) Annarita Falanga et al. Future Medicinal Chemistry
- Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment
- (2020) Laurène Fenwarth et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Specific functions of Exostosin-like 3 (EXTL3) gene products
- (2020) Shuhei Yamada CELLULAR & MOLECULAR BIOLOGY LETTERS
- Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments
- (2020) Annamaria Sandomenico et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Solubility, Stability, and Avidity of Recombinant Antibody Fragments Expressed in Microorganisms
- (2020) Tae Hyun Kang et al. Frontiers in Microbiology
- Emerging Treatment Options for the Treatment of Metastatic Urothelial Cancer: Therapeutic Potential of Enfortumab Vedotin
- (2020) Rohit K Jain et al. Cancer Management and Research
- Teclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma
- (2020) Kodandaram Pillarisetti et al. Blood Advances
- Crystal structure of CD38 in complex with daratumumab, a first-in-class anti-CD38 antibody drug for treating multiple myeloma
- (2020) Hyun Tae Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Immunotherapy Advances for Epithelial Ovarian Cancer
- (2020) Erin G. Hartnett et al. Cancers
- Trends in Monoclonal Antibody Production Using Various Bioreactor Syst
- (2020) I. Jyothilekshmi et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies
- (2019) Joseph Tintelnot et al. MOLECULAR CANCER THERAPEUTICS
- A novel method for determining antibody-dependent cellular phagocytosis
- (2019) Lynn Kamen et al. JOURNAL OF IMMUNOLOGICAL METHODS
- CIK cell-based delivery of recombinant adenovirus KGHV500 carrying the anti-p21Ras scFv gene enhances the anti-tumor effect and safety in lung cancer
- (2019) Xin-Rui Lin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A T-cell–engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer
- (2019) Akira Iizuka et al. CLINICAL CANCER RESEARCH
- Daratumumab in multiple myeloma
- (2019) Ajay K. Nooka et al. CANCER
- Efficient development and expression of scFv recombinant proteins against PD-L1 surface domain and potency in cancer therapy
- (2019) Muhammad Kalim et al. CYTOTECHNOLOGY
- Evaluation and use of an anti‐cynomolgus monkey CD79b surrogate antibody‐drug conjugate to enable clinical development of polatuzumab vedotin
- (2019) Dongwei Li et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions
- (2019) Soichiro Yamauchi et al. MOLECULES
- Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
- (2019) Jesús García-Foncillas et al. Frontiers in Oncology
- Novel human Ab against vascular endothelial growth factor receptor 2 shows therapeutic potential for leukemia and prostate cancer
- (2019) Ruei‐Min Lu et al. CANCER SCIENCE
- Mechanisms of Resistance to Monoclonal Antibodies (mAbs) in Lymphoid Malignancies
- (2019) Pallawi Torka et al. Current Hematologic Malignancy Reports
- Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients
- (2019) Jiwon Koh et al. Biomolecules
- Crystal structure of B-cell co-receptor CD19 in complex with antibody B43 reveals an unexpected fold
- (2018) Alexey Teplyakov et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Developments in the management of advanced soft-tissue sarcoma – olaratumab in context
- (2018) Gianluca Moroncini et al. OncoTargets and Therapy
- Anti-CD20 monoclonal antibodies: reviewing a revolution
- (2018) J. M. L. Casan et al. Human Vaccines & Immunotherapeutics
- Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells
- (2018) Fang-Rui Liu et al. BMC CANCER
- Moxetumomab Pasudotox: First Global Approval
- (2018) Sohita Dhillon DRUGS
- Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab Resistance
- (2017) Atrish Bagchi et al. MOLECULAR CANCER THERAPEUTICS
- Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer
- (2017) Xiaomin Liu et al. Oncotarget
- Tumorigenesis as a process of gradual loss of original cell identity and gain of properties of neural precursor/progenitor cells
- (2017) Ying Cao Cell and Bioscience
- Production of anti-amoxicillin ScFv antibody and simulation studying its molecular recognition mechanism for penicillins
- (2016) Jing Liu et al. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART B-PESTICIDES FOOD CONTAMINANTS AND AGRICULTURAL WASTES
- Antibody–drug conjugates for cancer therapy
- (2016) Anish Thomas et al. LANCET ONCOLOGY
- Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity
- (2016) Madelon Q. Wentink et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies
- (2016) Ronald P. Taylor et al. SEMINARS IN IMMUNOLOGY
- Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
- (2015) S. Arena et al. CLINICAL CANCER RESEARCH
- FDA Approval: Blinatumomab
- (2015) D. Przepiorka et al. CLINICAL CANCER RESEARCH
- Fcγ receptor pathways during active and passive immunization
- (2015) Stylianos Bournazos et al. IMMUNOLOGICAL REVIEWS
- Influence of molecular size on tissue distribution of antibody fragments
- (2015) Zhe Li et al. mAbs
- Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer
- (2015) Friederike Braig et al. Oncotarget
- Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity
- (2015) Robert G. E. Holgate et al. PLoS One
- Complement in monoclonal antibody therapy of cancer
- (2014) Laura M. Rogers et al. IMMUNOLOGIC RESEARCH
- Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties
- (2013) Christian Klein et al. mAbs
- Microbials for the production of monoclonal antibodies and antibody fragments
- (2013) Oliver Spadiut et al. TRENDS IN BIOTECHNOLOGY
- Fusion protein linkers: Property, design and functionality
- (2012) Xiaoying Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Brentuximab Vedotin
- (2012) C. Deng et al. CLINICAL CANCER RESEARCH
- Quantum Dot- Conjugated Anti-GRP78 scFv Inhibits Cancer Growth in Mice
- (2012) Weiming Xu et al. MOLECULES
- Monoclonal antibodies for the treatment of cancer
- (2012) Casey W. Shuptrine et al. SEMINARS IN CANCER BIOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Understanding and circumventing resistance to anticancer monoclonal antibodies
- (2010) Lina Reslan et al. mAbs
- Epitope mapping and key amino acid identification of anti-CD22 immunotoxin CAT-8015 using hybrid -lactamase display
- (2010) D. Bannister et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Molecular Modeling and Affinity Determination of scFv Antibody: Proper Linker Peptide Enhances Its Activity
- (2009) Xin Gu et al. ANNALS OF BIOMEDICAL ENGINEERING
- Panitumumab
- (2009) Eline A. Dubois et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action
- (2009) Royston Jefferis TRENDS IN PHARMACOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started